e-learning
resources
Vienna 2012
Wednesday, 05.09.2012
Pulmonary circulation: basic mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
microRNAs are deregulated in pulmonary arteries from COPD patients
M.M. Musri, V.I. Peinado, N. Coll, J. Altirriba, J. Garcia, D. Dominguez-Fandos, B. Lobo, R. Puig-Pey, J.A. Barberà (Barcelona, Spain; Geneva, Switzerland)
Source:
Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Session:
Pulmonary circulation: basic mechanisms
Session type:
Oral Presentation
Number:
4556
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M.M. Musri, V.I. Peinado, N. Coll, J. Altirriba, J. Garcia, D. Dominguez-Fandos, B. Lobo, R. Puig-Pey, J.A. Barberà (Barcelona, Spain; Geneva, Switzerland). microRNAs are deregulated in pulmonary arteries from COPD patients. Eur Respir J 2012; 40: Suppl. 56, 4556
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Expression of TGFβ-1 and TGFβ-1RII in pulmonary arteries of patients with severe COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 392s
Year: 2003
Gene expression of angiogenic factors in pulmonary arteries from COPD
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009
microRNA profiling in pulmonary fibroblasts in COPD
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Do COPD patients have a pulmonary vascular phenotype?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Decreased expression of VEGFR-2 mRNA in pulmonary vessels of COPD patients
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD
Year: 2009
Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Versican and collagen-III expression in bronchial and pulmonary muscular arteries in COPD patients
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Characterization of the cellular and extracellular changes in remodeled arteries of smokers and patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 491s
Year: 2001
microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
The study of pulmonary circulation in the patients with pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 415s
Year: 2001
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
Source: Eur Respir J 2002; 19: 632-638
Year: 2002
Clinical and investigational profiles of elevated pulmonary artery pressures in patients with stable chronic obstructive pulmonary diseases
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Micro-RNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010
Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012
Mechanisms underlying pulmonary vascular changes in COPD patients
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006
Morphology of pulmonary tissue in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 456s
Year: 2003
Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 416s
Year: 2001
The effectiveness of pulmonary rehabilitation in Russian patients with COPD complicated by pulmonary artery hypertension
Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept